Drug Recalls have several different levels. Some recalls are voluntarily issued by the drug companies themselves (such as the recent infant cough and cold medicine recall). These types of recalls do not involve notifications of individual patients. Grand Valley Health Plan monitors recalls affecting patients and has policies in place to deal with these instances.
Recalls involving notifications of individual patients are determined and issued by the FDA. When such a recall is issued, the recall information will be posted on this page.
The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA), is investigating a multistate fungal meningitis outbreak among patients who received contaminated steroid injections. Several patients suffered strokes that are believed to have resulted from their infections. The investigation also includes fungal infections associated with injections in a peripheral joint, such as a knee, shoulder or ankle.
CDC and public health officials are referring any patients who have symptoms that suggest possible fungal infection to their physicians, who can evaluate them further. Patients who received injections in peripheral joints only are not believed to be at risk for meningitis, but they could be at risk for joint infection.
For more information visit: http://www.fda.gov/Drugs/DrugSafety or speak with your Grand Valley Health Plan Provider.
If you have any additional questions regarding drug recalls, please contact one of our pharmacies listed below.